News for Genus plc (GNS.L)

Genus (GNS.L) issued trading update for fiscal year ended 30 June 2025. The Group said it recorded strong underlying Group trading in-line with expectations. As a result of good trading and the PRP milestone receipt, the Board now expects Group fiscal 2025 adjusted profit before tax to be at least 72 million pounds in actual currency.

Discover Genus plc's $0.1045/share semi-annual dividend details. Check payout dates, growth trends, and yields.

Genus plc (OTCPK:GENSF) Q2 2025 Earnings Conference Call February 27, 2025 3:30 AM ETCompany ParticipantsJorgen Kokke - CEOAlison Henriksen - CFOConference...

Release Date: February 27, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Genus PLC (G

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NGNS.L - Genus PLCHalf Year 2025 Genus PLC Earnings CallFeb 27, 2025 / 08:30AM GMT ============

Sachin Tendulkar’s mom-in-law paints a riveting portrait of her life in India

Earnings call: Genus reports progress amid market challenges, eyes FDA approval

Release Date: September 05, 2024For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Genus PLC (

Genus plc (OTCPK:GENSF) Q3 2024 Earnings Conference Call September 5, 2024 2:00 AM ETCompany ParticipantsJorgen Kokke - CEOAlison Henriksen - CFOConference...

“Animal Biotechnology Market” from 2024-2034 with covered segments By Product Type (Diagnostics Tests, Vaccines, Drugs, Reproductive and Genetic, Feed...

Enhancing Livestock Performance Through Advanced Animal Genetics Innovative Approaches to Boost Animal Productivity...

Feb 22, 2024 / 07:01AM GMTJorgen Kokke Genus plc-CEO Good morning, everyone, and thank you for joining us today. I am Jorgen Kokke, and I am the CEO of Genus pl

Earnings call: Genus plc faces profit dip amid strategic shifts

See more on positive outlook for Novo Nordisk's FY24 and highlights of achievements, progress in CagriSema, and expansion into cardiovascular disease.

Genus plc (OTCPK:GENSF) Q2 2024 Earnings Conference Call February 22, 2024 2:05 AM ETCompany ParticipantsJorgen Kokke - CEOAlison Henriksen - CFOConference...

BlackRock Throgmorton Trust plc Information disclosed in accordance with Article 5 Transparency Directive and DTR 4.1 Annual Results Announcement for the year ended 30 November 2021 PERFORMANCE... | February 7, 2022